TMPRSS2 and prostate cancer: While in some cancer types, like prostate cancer, TMPRSS2 is increased within the cancer tissue and correlates with poor survival rates, TMPRSS2 expression is decreased in lung cancer tissue, which correlates with poor outcomes.